AMLX insider trading
Amylyx Pharmaceuticals, Inc.
In the past 36 days, 6 insiders sold $3.8M.
Insider purchases
No open-market purchases by insiders in this period.
Insider sales
| Insider | Value | Holdings | Plan | Traded / filed |
|---|---|---|---|---|
George M Milne Jr Director |
$831K 30,000 sh @ $27.70 |
−3.7% | Pre-scheduled | Oct 5, 2026 Filed Oct 7, 2026 |
Joshua B Cohen Co-Chief Executive Officer |
$981K 30,464 sh @ $32.19 |
−0.8% | Not pre-scheduled | Sep 10, 2026 Filed Sep 14, 2026 |
Justin B. Klee Co-Chief Executive Officer |
$980K 30,464 sh @ $32.18 |
−0.8% | Not pre-scheduled | Sep 10, 2026 Filed Sep 14, 2026 |
James M Frates Chief Financial Officer |
$350K 10,810 sh @ $32.36 |
−4.4% | Not pre-scheduled | Sep 10, 2026 Filed Sep 14, 2026 |
Camille L Bedrosian Chief Medical Officer |
$325K 10,028 sh @ $32.40 |
−3.5% | Not pre-scheduled | Sep 10, 2026 Filed Sep 14, 2026 |
Gina Mazzariello Chief Legal Officer |
$310K 9,536 sh @ $32.46 |
−4.8% | Not pre-scheduled | Sep 10, 2026 Filed Sep 14, 2026 |